Chemoinformaics analysis of MYRICETIN-3-O-BETA-D-GLUCURONIDE
| Molecular Weight | 494.361 | nRot | 4 |
| Heavy Atom Molecular Weight | 476.217 | nRig | 25 |
| Exact Molecular Weight | 494.07 | nRing | 4 |
| Solubility: LogS | -3.959 | nHRing | 2 |
| Solubility: LogP | 0.171 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 17 |
| nHA | 13 | APOL | 58.3003 |
| nHD | 9 | BPOL | 25.0017 |
| QED | 0.203 |
| Synth | 4.209 |
| Natural Product Likeliness | 1.99 |
| NR-PPAR-gamma | 0.899 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.192 |
| HIA | 0.751 |
| CACO-2 | -6.609 |
| MDCK | 0.0000114 |
| BBB | 0.019 |
| PPB | 0.85746 |
| VDSS | 0.781 |
| FU | 0.171045 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.02 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.034 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.114 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.114 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.001 |
| CL | 2.081 |
| T12 | 0.952 |
| hERG | 0.012 |
| Ames | 0.301 |
| ROA | 0.038 |
| SkinSen | 0.252 |
| Carcinogencity | 0.026 |
| EI | 0.038 |
| Respiratory | 0.026 |
| NR-Aromatase | 0.634 |
| Antiviral | Yes |
| Prediction | 0.664883 |